Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.

[1]  S. Pileri,et al.  B-cells and mixed cryoglobulinemia. , 2007, Autoimmunity reviews.

[2]  A. Tarr,et al.  Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein , 2007, Journal of Virology.

[3]  A. Gloghini,et al.  HCV‐Related Immunocytoma and Type II Mixed Cryoglobulinemia‐Associated Autoantigens , 2007, Annals of the New York Academy of Sciences.

[4]  S. Pileri,et al.  HCV-related autoimmune and neoplastic disorders: the HCV syndrome. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  Patrice Cacoub,et al.  The pathophysiology of HCV induced B-cell clonal disorders. , 2007, Autoimmunity reviews.

[6]  D. Landau,et al.  Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. , 2007, Rheumatology.

[7]  C. Ferri,et al.  Hepatitis C virus-related lymphoproliferative disorders: an overview. , 2007, World journal of gastroenterology.

[8]  J. Piette,et al.  Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. , 2006, Arthritis and rheumatism.

[9]  Felicia A Tucci,et al.  HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations , 2006, Leukemia.

[10]  A. Alberti,et al.  Detailed analysis of the E2–IgM complex in hepatitis C‐related type II mixed cryoglobulinaemia , 2006, Journal of viral hepatitis.

[11]  G. Russo,et al.  Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1–69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis 1 , 2005, The Journal of Immunology.

[12]  A. Gabrielli,et al.  Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. , 2005, Archives of internal medicine.

[13]  M. Clementi,et al.  Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. , 2004, Virology.

[14]  Y. Matsuura,et al.  Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype , 2002, Journal of Virology.

[15]  A. Gasbarrini,et al.  Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries , 2001, Journal of Virology.

[16]  G. Fadda,et al.  Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. , 2001, Virology.

[17]  S. Levy,et al.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. , 2001, Blood.

[18]  A. Carbone,et al.  Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. , 2000, Blood.

[19]  G. Fadda,et al.  Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant fab fragments , 1998, Hepatology.

[20]  V. Agnello.  The Aetiology of Mixed Cryoglobulinaemia Associated with Hepatitis C Virus Infection , 1995, Scandinavian journal of immunology.

[21]  C. Barbas,et al.  Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.